Dermatology News

Monday, August 20, 2018
Researchers investigated the potential association between psoriasis and clinical markers of cognitive decline using data from the Rotterdam Study.
Friday, August 17, 2018

By Will Boggs MD

NEW YORK (Reuters Health) - Risankizumab, a monoclonal antibody that binds to the p19 subunit of interleukin-23, is effective for treating moderate-to-severe plaque psoriasis, according to results from two phase 3 trials.

Thursday, August 16, 2018
Patients with epidermolysis bullosa have a high risk of developing which cancer?
Thursday, August 16, 2018
Researchers investigated the association between newer dipeptidyl-peptidase 4 (DPP-4) inhibitors and the risk of developing bullous pemphigoid among patients with diabetes.
Tuesday, August 14, 2018
Researchers investigated whether a biologic increased the risk for serious infections among patients with psoriasis.
Monday, August 13, 2018
Recent study findings suggest that individuals who frequently develop basal cell carcinoma are at increased risk of developing other cancers such as breast and prostate cancer.
Friday, August 10, 2018
Dupilumab targets the interleukin (IL)-4 and IL-13 pathways by blocking which subunit?​​​​​​​
Wednesday, August 8, 2018

By Reuters Staff

NEW YORK (Reuters Health) - Adalimumab appears to be safe for treating pediatric patients with polyarticular juvenile idiopathic arthritis (JIA), enthesitis-related arthritis (ERA), psoriasis and Crohn's disease (CD), according to data from company-sponsored clinical trials.

Tuesday, August 7, 2018
Researchers conducted a systematic review and meta-analysis to determine the prevalence and incidence of various systemic diseases among patients with alopecia areata.
Friday, August 3, 2018
While sunless tanning may be a safe alternative, results from a recent study suggest that this method may not affect other risk factors associated with skin cancer.